Start here if you're new
what it is
Claritev helps hospitals and insurers catch billing mistakes, cut overcharges, and recover money that was paid wrong.
how it gets paid
Last year Claritev made $965M in revenue. Network Solutions was the main engine at $340M, or 35% of sales.
why it's growing
Revenue grew 3.7% last year. The company also reported $151.3M of adjusted EBITDA.
what just happened
Claritev posted $246.6M of quarterly revenue and an $80.6M net loss.
At a glance
C balance sheet — red flag territory — real financial stress
5/100 earnings predictability — expect surprises
1.2% return on capital — nothing to write home about
-$29.08 fy2024 eps est
$931M fy2024 rev est
xvary composite: 13/100 — weak
What they do
Claritev helps hospitals and insurers catch billing mistakes, cut overcharges, and recover money that was paid wrong.
Your hospital does not rip out billing systems for fun. Claritev sits inside claims work tied to $965M of annual revenue, so leaving means redoing daily processes. It also has 2,700 employees, which is a lot of payroll for a company with a $280M market cap.
How they make money
$965M
annual revenue · their business grew +3.7% last year
Network Solutions
$340M
+5.5%
Payment and Revenue Integrity
$225M
+4.0%
Analytics-Based Services
$180M
+3.0%
Contracted Network Services
$140M
0.0%
Outsourced Network Development
$80M
+2.0%
The products that matter
claims processing and cost management
Network Solutions
$579M · 60% of revenue mix
it generated $579M of the company's $965M in segment revenue. this is the scale engine, even if it is not the most interesting margin story.
60% of mix
claims auditing and payment recovery
Payment & Revenue Integrity
$386M · 40% of revenue mix
it produced $386M of segment revenue, and management points to a 61.4% adjusted EBITDA margin. smaller segment. bigger part of the thesis.
61.4% margin
Key numbers
$4.6B
debt load
This is the bill sitting ahead of equity. If cash flow slips, debt gets paid before you do.
$965M
annual revenue
This is the top line for the whole business. It tells you the company is large enough to matter, but not large enough to ignore leverage.
3.0%
operating margin
Only 3 cents of every sales dollar stay after operating costs. That leaves very little room for a bad quarter.
1.2%
return on capital
The business is squeezing little profit from a lot of capital. That is fine for a utility and awkward for a stock.
Financial health
C
strength
- balance sheet grade C — very weak — significant financial distress
- risk rank 5 — safer than 5% of stocks
- price stability 5 / 100
- long-term debt $4.6B (94% of capital)
C — balance sheet grade and long-term debt are flagged. this stock carries more risk than average.
Total return vs. market
Return history isn't available for CTEV right now.
source: institutional data · return history unavailable
What just happened
missed estimates
Claritev posted $246.6M of quarterly revenue and an $80.6M net loss.
The company also reported $151.3M of adjusted EBITDA, which is a profit proxy that strips out some costs. That 61.4% margin is strong, but the bottom line still lost money.
$246.6M
revenue
-$4.23
eps
n/a
n/a
the number that mattered
The $80.6M net loss mattered most. It shows revenue growth did not cleanly turn into shareholder profit.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
The #1 risk is $4.55B of debt against a $280M equity value.
med
Debt overwhelms the equity
Long-term debt is $4.55B, or 94% of capital. The balance sheet grade is C. When the debt stack is this large, small operational misses hit equity holders harder.
At roughly 16 times the market cap, leverage is not a side note. It is the main character.
med
Margin quality has to survive the turnaround
The 61.4% adjusted EBITDA margin is the bullish fact on the page. But the latest quarter still showed an $80.6M net loss, which tells you interest, amortization, and other costs are doing real damage below EBITDA.
If that margin slips before free cash flow turns positive, the equity story gets thinner fast.
med
The free-cash-flow target leaves no cushion
Management's 2026 free cash flow guide is $0–$10M. That is progress if they hit it. It is also tiny next to a $4.55B debt load.
Missing that range would tell you the operating turnaround is not converting into balance-sheet relief.
A business can survive with slow growth or heavy debt. Having both at once is where equities get hurt.
source: institutional data · regulatory filings · risk analysis
Pay attention to
calendar
q1 2026 earnings report
Expected may 7, 2026. You want to see whether the latest margin strength survives another quarter.
metric
2026 free cash flow
Management guided to $0–$10M. If the number lands near zero, the debt story does not get easier.
risk
debt versus buybacks
A $75M repurchase looks shareholder-friendly. With $4.55B of debt and ongoing losses, you should care more about balance-sheet math than optics.
trend
2026 revenue guide of $980M–$1B
That guide implies some growth from the $931M fiscal estimate. The number that matters is whether growth arrives without margin erosion.
Analyst rankings
earnings predictability
5 / 100
in human-speak, analysts do not see a stable earnings pattern here. expect sharp revisions and noisy quarters.
risk rank
5
This places the stock near the risky end of the market. Translation: you are not getting paid for safety here.
source: institutional data
Institutional activity
institutional ownership data for CTEV is being compiled.
source: institutional data
Price targets
3-5 year target range
n/a
n/a
$32
current price
n/a
target midpoint · n/a from current
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive